Clinic program aims to close COVID-19 vaccine gap for vulnerable patients
NCT ID NCT06469788
Summary
This study is testing a new clinic-based program designed to help more Black and Latinx adults with autoimmune rheumatic diseases get the updated COVID-19 vaccine. Researchers want to see if providing better information and addressing access issues can increase vaccination rates in these communities, which have been hit harder by COVID-19. The program is being tested in Alabama and Massachusetts with over 1,000 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Brigham Women's Hospital
NOT_YET_RECRUITINGBoston, Massachusetts, 02115, United States
Contact Email: •••••@•••••
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Massachusetts Chan Medical School
NOT_YET_RECRUITINGWorcester, Massachusetts, 01655, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.